These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16182816)

  • 1. Combined use of tacrolimus and sirolimus in de novo renal transplant patients: current data.
    Ribes D; Kamar N; Esposito L; Rostaing L
    Transplant Proc; 2005; 37(6):2813-6. PubMed ID: 16182816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):252-8. PubMed ID: 14742990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential pharmacokinetic interaction of tacrolimus and cyclosporine on everolimus.
    Kovarik JM; Curtis JJ; Hricik DE; Pescovitz MD; Scantlebury V; Vasquez A
    Transplant Proc; 2006 Dec; 38(10):3456-8. PubMed ID: 17175302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcineurin inhibitors in renal transplantation still needed but in reduced doses: a review.
    Ponticelli C; Scolari MP
    Transplant Proc; 2010; 42(6):2205-8. PubMed ID: 20692445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
    Flechner SM; Kobashigawa J; Klintmalm G
    Clin Transplant; 2008; 22(1):1-15. PubMed ID: 18217899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus and mycophenolate mofetil after liver transplantation.
    Kniepeiss D; Iberer F; Grasser B; Schaffellner S; Tscheliessnigg KH
    Transpl Int; 2003 Jul; 16(7):504-9. PubMed ID: 12687325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion from cyclosporine to sirolimus in stable renal transplant recipients.
    Sennesael JJ; Bosmans JL; Bogers JP; Verbeelen D; Verpooten GA
    Transplantation; 2005 Dec; 80(11):1578-85. PubMed ID: 16371929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved renal function after conversion from tacrolimus/sirolimus to tacrolimus/mycophenolate mofetil in kidney transplant recipients.
    Augustine JJ; Chang PC; Knauss TC; Aeder MI; Bodziak KA; Schulak JA; Hricik DE
    Transplantation; 2006 Apr; 81(7):1004-9. PubMed ID: 16612276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of mycophenolic acid in kidney transplant patients receiving sirolimus versus cyclosporine.
    El Haggan W; Ficheux M; Debruyne D; Rognant N; Lobbedez T; Allard C; Coquerel A; Ryckelynck JP; Hurault de Ligny B
    Transplant Proc; 2005 Mar; 37(2):864-6. PubMed ID: 15848558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal function and histology in kidney transplant patients receiving tacrolimus and sirolimus or mycophenolate mofetil.
    Kamar N; Van TT; Ribes D; Modesto A; Cointault O; Lavayssière L; Ader JL; Durand D; Rostaing L
    Exp Clin Transplant; 2006 Dec; 4(2):532-6. PubMed ID: 17238854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus-based immunosuppression with reduce dose cyclosporine or tacrolimus after renal transplantation.
    Formica RN; Lorber KM; Friedman AL; Bia MJ; Lakkis F; Smith JD; Lorber MI
    Transplant Proc; 2003 May; 35(3 Suppl):95S-98S. PubMed ID: 12742475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
    Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S;
    Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined sirolimus-calcineurin inhibitor immunosuppressive therapy in simultaneous heart and kidney transplantation: a retrospective analysis of a single hospital's experience.
    Hsu KH; Chou NK; Tsai MK; Chi NH; Chen YS; Yu HY; Wang CH; Ko WJ; Tsao CI; Lee PH; Wang SS
    Transplant Proc; 2010 Apr; 42(3):934-7. PubMed ID: 20430208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion to combined therapy with sirolimus and mycophenolate mofetil improved renal function in stable renal transplant recipients.
    Tsai MK; Lee CY; Hu RH; Lee PH
    J Formos Med Assoc; 2007 May; 106(5):372-9. PubMed ID: 17561472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil vs. sirolimus in kidney transplant recipients receiving tacrolimus-based immunosuppressive regimen.
    Sampaio EL; Pinheiro-Machado PG; Garcia R; Felipe CR; Park SI; Casarini DE; Moreira S; Franco MF; Tedesco-Silva H; Medina-Pestana JO
    Clin Transplant; 2008; 22(2):141-9. PubMed ID: 18339132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB
    Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study.
    Lebranchu Y; Thierry A; Toupance O; Westeel PF; Etienne I; Thervet E; Moulin B; Frouget T; Le Meur Y; Glotz D; Heng AE; Onno C; Buchler M; Girardot-Seguin S; Hurault de Ligny B
    Am J Transplant; 2009 May; 9(5):1115-23. PubMed ID: 19422337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus-Based Immunosuppressive Regimens in Renal Transplantation: A Systemic Review.
    Zhao DQ; Li SW; Sun QQ
    Transplant Proc; 2016; 48(1):3-9. PubMed ID: 26915834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.